|
[1]HU Q, LIU W, SHAO H.Research progress of pharmacotherapy drug-induced liver injury[J].Chin J Clin Pharmacol Ther, 2016, 21 (2) :231-236. (in Chinese) 胡琴, 刘维, 邵宏.药物性肝损伤的药物治疗研究进展[J].中国临床药理学与治疗学, 2016, 21 (2) :231-236.
|
|
[2]LI C, LIU HL, ZHU B, et al.Research of etiologies and clinical features of unknown origin jaundice patients[J].China J Modern Med, 2014, 24 (21) :64-69. (in Chinese) 李晨, 刘鸿凌, 朱冰, 等.黄疸待查患者病因及临床特点的研究[J].中国现代医学杂志, 2014, 24 (21) :64-69.
|
|
[3]SUN YH, LIN ZM, XIANG XG, et al.Clinical analysis of 2510patients with abnormal liver function test of unknown etiology[J].Chin Hepatol, 2016, 21 (8) :623-625. (in Chinese) 孙艳华, 林之莓, 项晓刚, 等.不明原因肝功能异常2510例临床资料分析[J].肝脏, 2016, 21 (8) :623-625.
|
|
[4]ZHANG YM, SUN WJ, WEN LZ, et al.Clinical features of patients with drug-induced liver injury in China in the last five years[J].J Clin Hepatol, 2018, 34 (3) :562-566. (in Chinese) 张艳梅, 孙文静, 文良志, 等.近5年我国药物性肝损伤患者临床特征分析[J].临床肝胆病杂志, 2018, 34 (3) :562-566.
|
|
[5]CHALASANI NP, HAYASHI PH, BONKOVSKY HL, et al.ACGClinical Guideline:The diagnosis and management of idiosyncratic drug-induced liver injury[J].Am J Gastroenterol, 2014, 109 (7) :950-966, 967.
|
|
[6]Drug-Induced Liver Disease Study Group, Chinese Society of Hepatology, Chinese Medical Association.Guidelines for the management of drug-induced liver injury[J].J Clin Hepatol, 2015, 31 (11) :1752-1769. (in Chinese) 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志, 2015, 31 (11) :1752-1769.
|
|
[7] DONAT M, CONFORTI A, LENTI MC, et al.Risk of acute and serious liver injury associated to nimesulide and other NSAIDs:Data from drug-induced liver injury case-control study in Italy[J].Br J Clin Pharmacol, 2016, 82 (1) :238-248.
|
|
[8]WANG JJ, ZHAO P.Research progress in clinical application of S-adenosyl methionine[J/CD].Chin J Liver Dis:Electronic Edition, 2011, 3 (1) :57-60. (in Chinese) 王建军, 赵平.S-腺苷蛋氨酸临床应用研究进展[J/CD].中国肝脏病杂志:电子版, 2011, 3 (1) :57-60.
|
|
[9]LI XY.Effectiveness and safety of adenosine methionine in treatment of cholestatic hepatitis[J].Clin Res Pract, 2016, 1 (13) :36-37. (in Chinese) 李向阳.丁二磺酸腺苷蛋氨酸治疗胆汁淤积性肝炎的有效性与安全性分析[J].临床医学研究与实践, 2016, 1 (13) :36-37.
|
|
[10]ZHANG WW, SHEN L, CHI J, et al.Research on S-adenosyl methionine in treating patients with drug induced cholestatic liver diseases associated with depression/anxiety[J/CD].Chin J Liver Dis:Electronic Edition, 2015, 7 (3) :96-99. (in Chinese) 张巍巍, 沈磊, 迟静, 等.S-腺苷蛋氨酸治疗药物性胆汁淤积性肝病伴抑郁/焦虑患者的研究[J/CD].中国肝脏病杂志:电子版, 2015, 7 (3) :96-99.
|
|
[11]HOU FQ, ZENG Z, WANG GQ.Hospital admissions for drug-induced liver injury:clinical features, therapy, and outcomes[J].Cell Biochem Biophys, 2012, 64 (2) :77-83.
|
|
[12]FONTANA RJ, HAYASHI PH, GU J, et al.Idiosyncratic druginduced liver injury is associated with substantial morbidity and mortality within 6 months from onset[J].Gastroenterology, 2014, 147 (1) :96-108.
|
|
[13]BJRNSSON E, TALWALKAR J, TREEPRASERTSUK S, et al.Drug-induced autoimmune hepatitis:Clinical characteristics and prognosis[J].Hepatology, 2010, 51 (6) :2040-2048.
|
|
[14]HISAMOCHI A, KAGE M, IDE T, et al.An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis[J].J Gastroenterol, 2016, 51 (6) :597-607.
|
|
[15]de LEMOS AS, FOUREAU DM, JACOBS C, et al.Drug-induced liver injury with autoimmune features[J].Semin Liver Dis, 2014, 34 (2) :194-204.
|
DownLoad: